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Background and Purpose: Blepharospasm (BSP) and apraxia of eyelid opening (AEO) have been reported as 
dystonia related with parkinsonism. However, systematic analysis of clinical characteristics of BSP and AEO in 
parkinsonism has been seldom reported. To investigate the clinical characteristics of BSP and AEO in parkinsonism 
and to find out the clinical significance to differentiate parkinsonism.
Methods: We enrolled 35 patients who had BSP with or without AEO out of 1113 patients with parkinsonism (913 
IPD, idiopathic Parkinson’s disease; 190 MSA, multiple system atrophy, 134 MSA-p, 56 MSA-c and 10 PSP, 
progressive  supranuclear  palsy).  We  subdivided  MSA  into  MSA-p  (predominantly  parkinsonism)  and  MSA-c 
(predominantly cerebellar) according to the diagnostic criteria proposed by Quinn. We analyzed the clinical features 
of BSP and parkinsonism including onset age, onset interval to BSP, characteristics of BSP, presence of AEO, 
coexisted dystonias on the other body parts, severity of parkinsonism and relationship with levodopa treatment. 
Results: BSP with or without AEO were more frequently observed in atypical parkinsonism (PSP, 70%; MSA-p, 
11.2%; MSA-c, 8.9%) than in IPD (0.9%). Reflex BSP was observed only in atypical parkinsonism (4 MSA-p, 1 
MSA-c and 2 PSP). BSP preceding parkinsonism (Pre-BSP) was observed mainly in atypical parkinsonism (2 
MSA-p, 1 MSA-c, 1 PSP and 1 IPD). The presence of AEO was more frequent in atypical parkinsonism than in 
IPD, but isolated AEO was not detected. BSP related to levodopa ('off' symptom or ‘peak-dose’ effect) were 
observed only in IPD.
Conclusions: Reflex BSP, Pre-BSP and the presence of AEO may be a unique feature of atypical parkinsonism. 
BSP related to levodopa might be representative of IPD. No differences were found in the clinical features of BSP 
between MSA-p and MSA-c.
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INTRODUCTION
Blepharospasm (BSP) is a focal dystonia characterized 
by repetitive involuntary sustained contractions of the 
orbicularis oculi muscle, causing spasmodic closure of 
the eyelids.
1-3 It is frequently found in association with 
apraxia of eyelid opening (AEO).
4 AEO has been 
described as a non-paralytic motor abnormality charac-
terized by difficulty in opening the eyes at will in the 
absence of visible contraction of the orbicularis oculi 
muscle.
4-6 When BSP occurs only in response to certain 
stimuli, such as a sudden visual threat or auditory or 
tactile stimulus, it is defined as reflex blepharospasm Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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Figure 1. EMG of the levator palpebrae (LP) and orbicularis oculi 
(OO) in the normal individual (A), in the MSA-p patient with 
blepharospasm (B) and in the patient with blepharospasm and 
apraxia of eyelid opening (C). Comparing with normal finding (A),
EMG showed a marked contraction of OO (white arrow) during 
eye opening (gray line) (B). During eye opening, OO inhibition 
was incomplete (gray arrow) and LP contraction was not sustained
(black arrow) (C). 
(R-BSP).
3,7
Most of these ocular symptoms, such as BSP, are not 
associated with another identifiable associated disease. In 
this case, they are referred to as primary or idiopathic.
4,5,7 
However, secondary BSP has occasionally been reported 
in patients with parkinsonism and in those with focal 
lesions in the basal ganglia, diencephalon, or brainstem, 
in addition to those with an ophthalmologic disorder.
8-12 
AEO has been occasionally reported in patients with 
focal cerebral lesions and parkinsonism, particularly in 
those with progressive supranuclear palsy (PSP).
6,13-15 
Moreover, BSP and AEO have been reported as an 
coexisting dystonia in atypical parkinsonism, and are 
more commonly present in PSP.
16 However, their 
clinical relationships are unclear, neither has it rarely 
been reported which disorder is related to several types 
of BSP.
Because there are no large clinical studies on several 
types of BSP such as reflex BSP (R-BSP) or preceding 
BSP prior to parkinsonism (Pre-BSP) in the literatures, 
we prospectively surveyed these symptoms in patients 
with parkinsonism. In the case of already existing BSP 
associated with parkinsonism, we retrospectively analyzed 
the characteristics and time intervals of BSP. We 
analyzed clinical features of BSP and AEO in patients 
with idiopathic Parkinson’s disease (IPD), multiple 
system atrophy (MSA), and PSP. We subdivided MSA 
into MSA-p (predominantly parkinsonism) and MSA-c 
(predominantly cerebellar) satisfying diagnostic criteria 
proposed by Quinn.
17 Similarly, BSP was subclassified 
into R-BSP, Pre-BSP, and BSP combined with AEO, 
and these subtypes were then analyzed individually.
Our aims were to investigate the clinical charac-
teristics of BSP and AEO associated with various types 
of parkinsonism and to find out if there is any clinical 
significance of BSP to differentiate parkinsonism inclu-
ding subtypes of MSA.
MATERIALS AND METHODS
1. Patient Selection
We enrolled 35 patients with BSP with or without 
AEO among 1113 patients with parkinsonism registered 
at the Movement Disorder Clinic of Samsung Medical 
Center from January 2002 to December 2003. Using the 
established diagnostic criteria for IPD,
18 MSA
17,19 and 
PSP,
20 the 1113 patients with parkinsonism were 
subclassified as having; IPD (913 patients), probable 
MSA (190 patients; 134 MSA-p and 56 MSA-c), or 
probable PSP (10 patients). We subdivided MSA into 
MSA-p (predominantly parkinsonism) and MSA-c 
(predominantly cerebellar) satisfying diagnostic criteria Yoon WT, et al. Clinical Analysis of Blepharospasm and Apraxia of Eyelid Opening in Patients with Parkinsonism 
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proposed by Quinn.
17 We clinically diagnosed BSP using 
the established definition.
3,7 In the case of those with 
coexisting BSP and parkinsonism, we retrospectively 
analyzed the characteristics and time intervals of BSP. 
For diagnosis of AEO, we used diagnostic criteria 
proposed by Lepore and Duvoisin.
6 These included (i) 
no sign of ongoing orbicularis oculi contractions such as 
lowering of the brows beneath the superior orbital 
margin; (ii) marked frontalis muscle overaction during 
period of inability to raise eyelids; (iii) no ocular 
motor/ocular sympathetic nerve dysfunction and ocular 
myopathy. To confirm the presence of AEO with BSP, 
we performed electromyography (EMG) on the orbic-
ularis oculi (OO) and levator palpebrae (LP) muscles 
(Fig. 1) in 13 patients who were diagnosed by above 
diagnostic criteria. We included patients with long-term 
follow up for maximum 24 months, full evaluations for 
parkinsonism, and a clinical diagnosis confirmed by at 
least two special neurologists based at Movement Dis-
order Clinic.
2. Periocular Electromyography
After getting the patient’s informed consent, muscle 
activities from the orbicularis oculi and levator palpebrae 
were recorded by means of 2 channel- EMG (Nicolet 
Biomedical Inc., Medicine, Wisconsin, USA), using 
monopolar needle electrodes inserted into the left upper 
lid. Proper placement of the needles was confirmed by 
muscle activities at the opening and closing of the lid. 
Reference surface electrodes were spaced about 1cm 
apart from the active electrodes on the orbital bony 
prominence. A ground electrode was fixed in the middle 
of the forehead. Trials of opening and closing of eyes 
were repeated several times to acquire optimal signals. 
The EMG signals were amplified in a conventional 
manner, filtered (10-1,000 Hz), displayed on a memory 
oscilloscope, and analyzed offline.
3. Clinical analysis 
We analyzed the clinical features of BSP and parkin-
sonism including demography, onset age, onset interval 
to BSP, clinical diagnosis of parkinsonism, severity of 
parkinsonism, and relationship with levodopa treatment. 
Severity of motor symptoms of parkinsonism was 
evaluated by using motor UPDRS (part III of Unified 
Parkinson’s Disease Rating Scale). To analyze the 
characteristics of BSP, we subclassified reflex BSP 
(R-BSP), BSP preceding parkinsonism (Pre-BSP), or 
BSP combined with AEO. R-BSP was defined when 
BSP occurred only in response to certain stimuli, such 
as a sudden visual threat or auditory or tactile stimulus.
3,7 
Pre-BSP was defined when BSP existed before 
presenting parkinsonism. Figure 1 showed EMG findings 
of EMG of BSP with or without AEO. Comparing with 
normal finding (Fig. 1-A), EMG showed a marked 
contraction of OO during eye closure (Fig. 1-B, 1-C). 
During eye opening, OO inhibition was incomplete and 
LP contraction was not sustained in BSP with AEO 
(Fig. 1-B). We also evaluated the coexistence of dystonia 
on other body parts.
4. Statistical analysis
All data are presented as means±standard error of 
mean (SEM). SPSS (version 12.0) program for windows 
(SPSS, Inc., Chicago, IL) was used for the statistical 
analysis. Sex differences and clinical characteristics of 
BSP data were analyzed using the Chi-square test. Onset 
age, onset interval to by parkinsonism, and severity of 
parkinsonism data were analyzed by using one-way 
ANOVA. Scheffe’s test was used for post hoc compari-
sons. A p value of <0.05 was used as the criterion for 
statistical significance.
RESULTS
1. Clinical characteristics of BSP
Thirty-five BSP patients with parkinsonism (mean 
age, 61.2±7.2 years), 19 men and 16 women, were 
enrolled in the study. Of these 35 BSP patients, 8 
(22.8%) were diagnosed as having IPD, 15 (42.9%) as 
MSA-p, 5 (14.3%) as MSA-c and 7 (20%) as probable 
PSP. Of the 913 patients with IPD 8 (0.9%) had BSP, 
15 of 134 (11.2%) patients with MSA-p, 5 of 56 patients Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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Patients IPD PSP MSA-p MSA-c
BSP / Total N.
Sex (M / F)
Onset age (y) : initial Symptom
Onset interval (y) : to BSP
Motor UPDRS
a
8 / 913 (0.9%)
6 / 2 (364 / 549)
b
55.3±12.4
2.8±3.8
8.9±1.6
7 / 10 (70%)
b
6/1  ( 7/3 )
60.9±5.0
2.1±4.6
8.3±2.8
15 / 134 (11.2%)
b
11 / 4 (71 / 63)
62.6±7.8
2.9±3.2
10.4±3.3
5 / 56 (8.9%)
0/5  ( 2 6/3 0 )
62.8±4.5
 2.8±3.1
 8.2±2.7
IPD: idiopathic Parkinson`s disease, PSP: progressive supranuclear palsy, MSA: multiple system atrophy, BSP: blepharospasm, UPDRS: 
Unified Parkinson’s Disease Rating Scale. 
apart III of UPDRS. Data represent mean±SEM. 
bP<0.05 by Chi-square test (for sex 
difference) and one-way ANOVA test (for other parameters).
Table 1. Demographic features of each form of parkinsonism
BSP (n=35) R-BSP (n=7) Pre-BSP (n=5) BSP+AEO (n=13)
Patients
Sex (M / F)
Onset age (y)
Motor UPDRS
a
19 / 16
61.2±7.2
 9.6±3.0
5/2
57.3±11.2
10.2±3.7
4/1
48.7±14.2
9.8± 3.4
7/6
59.7±10.2
9.3±3.1
Parkinsonism
IPD (N=913)
Atypical (N=200)
PSP (N=10)
MSA (N=190) (-p / -c)
MSA-P / MSA-C
8
27
b
7
20 (15 / 5)
15 / 5
0
7
b
2
5 (4 / 1)
4/1
1
4
b
1
3 (2 / 1)
2/1
3
10
b
3
7 (4 / 3)
4/3
BSP: blepharospasm, R-BSP: reflex blepharospasm, Pre-BSP: preceding blepharospasm prior to parkinsonism, BSP+AEO: blepharospasm 
with apraxia of eyelid opening, UPDRS: Unified Parkinson`s Disease Rating Scale, IPD: idiopathic Parkinson`s disease, PSP: progressive 
supranuclear palsy, MSA: multiple system atrophy, MSA-P: MSA parkinsonism predominant, MSA-C: MSA cerebellar predominant.
apart III of UPDRS. Data represent mean±SEM. 
bP<0.05 by Chi-square test (compared atypical parkinsonism with IPD).
Table 2. Demographic features and clinical significance of subclassification by BSP in parkinsonism 
(8.9%) with MSA-c, and 7 of 10 patients (70%) with 
PSP had BSP. BSP was more frequent in PSP and MSA 
than in IPD (p<0.05). In terms of sex differences, in 
contrast to the lack of gender preference in MSA-p, BSP 
was more frequent in men than women in IPD and in 
PSP. BSP with MSA-c only affected women. With 
except of these findings, no other significant clinical 
demographic difference was observed among various 
types of parkinsonism (Table 1).
2. Clinical significance of subtypes of BSP for 
differentiating parkinsonism
According to BSP subtype, i.e., R-BSP, Pre-BSP, and 
BSP with AEO, no significant differences were found 
between the parkinsonism types with respect to sex, age 
of onset, or severity of parkinsonism (Table 2). Seven of 
35 BSP patients (20%) showed R-BSP. All R-BSP 
patients had been clinically diagnosed as having atypical 
parkinsonism (4 MSA-p, 1 MSA-c, and 2 PSP) (Table 
2). Pre-BSP was observed in 5 of 35 BSP patients 
(14.3%: 1 IPD, 2 MSA-p, 1 MSA-c and 1 PSP), and 
was more frequently observed in atypical parkinsonism 
than in IPD (p<0.05). In our study, 13 of 35 patients 
with BSP (37.1%: 3 IPD, 4 MSA-p, 3 MSA-c and 3 
PSP) showed combined AEO. The presence of AEO was 
more frequent in atypical parkinsonism than in IPD (p 
<0.05), but isolated AEO was not detected (Table 2). Yoon WT, et al. Clinical Analysis of Blepharospasm and Apraxia of Eyelid Opening in Patients with Parkinsonism 
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Parkinsonism
Forms of combined dystonia
Cervical dystonia Facial dystonia Limb dystonia Camptocormia
IPD (N=913)
Atypical (N=200)
PSP (N=10)
MSA (N=190) (-p / -c)
0
4
1
3 (1 / 2)
0
1
0
1 (1 / 0)
1
0
0
0
2
1
0
1 (1 / 0)
IPD: idiopathic Parkinson’s disease, PSP: progressive supranuclear palsy, MSA: multiple system atrophy, unable to analyze statistically 
due to small number.
Table 3. Other forms of dystonia combined with BSP in parkinsonism
In terms of the relationship between BSP and 
levodopa treatment, BSP occurred as an ‘off’ symptom in 
two IPD patients and as a “peak-dose” effect in one IPD 
patient. In 3 IPD patients and in 1 MSA patient, BSP 
was improved by levodopa medication. However, one 
PSP patient presented aggravation of BSP after levodopa 
medication.
3. BSP combined with other types of dystonia in 
parkinsonism 
Nine (25.7%) of 35 BSP patients also had other types 
of dystonia. Types of dystonia and the clinical diagnoses 
of these patients were as follows; 4 with cervical 
dystonia (1 MSA-p, 2 MSA-c and 1 PSP), 3 with campto-
cormia - meaning forward bending of truncal muscles (2 
IPD and 1 MSA-p), 1 with limb dystonia (1 IPD), and 
1 with facial dystonia (1 MSA-p) (Table 3).
DISCUSSION
In this study, we prospectively surveyed BSP in 
patients with parkinsonism. In cases with coexisting BSP 
and parkinsonism, we retrospectively analyzed the charac-
teristics and time intervals of BSP.
BSP is considered to be one of the more common 
forms of focal dystonia in patients with IPD and atypical 
parkinsonism.
21 In our clinical series, by noting the 
frequencies of BSP among each group with parkin-
sonism, BSP was found to occur more frequently in 
atypical parkinsonism, MSA, and PSP than in IPD. 
However, no significant difference was found between 
the frequencies of BSP between subtypes of MSA, 
MSA-p and MSA-c.
In a recent report about BSP in IPD, gender was not 
found to be associated with the presence of BSP in 
IPD.
12 According to another case study about dystonia in 
MSA, dystonia was observed twice as frequently in 
women.
22 In our study, BSP with MSA-c only affected 
women. Our study also showed that BSP patients were 
mainly men in IPD and PSP, but than the gender were 
similarly represented in MSA-p.
According to previous studies,
4-6,23 AEO either combined 
with or without BSP may occur in parkinsonism, 
especially in PSP. In the present study, we found that 13 
of 35 patients (37.1%) with BSP showed AEO, and that 
BSP with AEO was more frequently detected in atypical 
parkinsonism. Although AEO might occur in many 
neurological disorders, we did not observe isolated AEO 
associated with parkinsonism.
The subclassification of BSP into R-BSP, Pre-BSP, 
and BSP with AEO was found to be more clinically 
helpful for the diagnosis of atypical parkinsonism, such 
as MSA and PSP. The present study suggests that 
R-BSP is a unique feature of atypical parkinsonism, 
because it was observed only in atypical parkinsonism. 
Although one study reported that idiopathic BSP does 
not lead to a parkinsonian syndrome,
24 patients with 
Pre-BSP have a tendency to be diagnosed with atypical 
parkinsonism after long-term follow up. This finding 
contrasts with previous studies that presented patients 
with BSP only at advanced stage disease.
11,25,26
No differences were observed in the clinical features 
of BSP between MSA-p and MSA-c despite a previous 
report that dystonia is common in untreated MSA-p.
22 Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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These findings support that BSP can be associated with 
any subtype of MSA.
The majority of previous studies have suggested that 
various types of dystonia can be observed in parkin-
sonism.
16,21,22,27 We observed that other types of dystonia 
coexisted with BSP and AEO in parkinsonism. Accor-
ding to our study, even though we were unable to 
perform a statistical analysis due to small numbers, we 
presume that BSP combined with cervical dystonia or 
facial dystonia is more frequently related to atypical 
parkinsonism, whereas camptocormia or limb dystonia is 
more frequently related to IPD.
In terms of the relationship between BSP and levo-
dopa treatment, we found that BSP might have occurred 
as an ‘off’ symptom or as a ‘peak dose’ effect of 
levodopa treatment in IPD. BSP that was improved by 
levodopa treatment was more frequently related to IPD, 
whereas BSP aggravated by levodopa treatment was 
more related to atypical parkinsonism. However, these 
suggestions were not statistically confirmable because of 
small patient numbers. Nevertheless, these relations are 
likely to be encountered in clinical medicine, and present 
a good clinical study topic for differential diagnosis in 
parkinsonism.
In conclusion, our study shows that BSP either with 
or without AEO is more frequently observed in atypical 
parkinsonism than in IPD, and suggests that R-BSP is a 
unique feature of atypical parkinsonism. In addition, our 
findings suggest that patients with Pre-BSP have a 
tendency to be diagnosed with atypical parkinsonism 
later, and that the presence of AEO indicates atypical 
parkinsonism. However, levodopa related BSP, including 
‘off’ symptom, ‘peak-dose’ effect, or levodopa respon-
siveness were found to represent IPD rather than 
atypical parkinsonism. No differences were found 
between the clinical features of BSP in MSA-p and 
MSA-c.
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